The staining results showed that the immunoreactivity for KPNA1 was significantly lower in the cervical cancer tissues than the normal tissues, whereas KPNA2 displayed the opposite trend, with increasing immunostaining in the cervical cancer tissue over the normal tissue (Figure 1A). This evidence concerns the gene KPNA1 and cervical carcinoma.